Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Life Sciences
When The Cure Kills—Cbd Limits Biodiversity Research, Zhiwei Liu, Kaniyarikkal Divakaran Prathapan, Rohan Pethiyagoda, Kamaljit Bawa, Peter Raven, Priyadarsanan Rajan
When The Cure Kills—Cbd Limits Biodiversity Research, Zhiwei Liu, Kaniyarikkal Divakaran Prathapan, Rohan Pethiyagoda, Kamaljit Bawa, Peter Raven, Priyadarsanan Rajan
Faculty Research & Creative Activity
The Convention on Biological Diversity(CBD) commits its 196 nation partiesto conserve biological diversity, useits components sustainably, and sharefairly and equitably the benefits fromthe utilization of genetic resources. Thelast of these objectives was further codifiedin the Convention’s Nagoya Protocol (NP),which came into effect in 2014. Althoughthese aspirations are laudable, the NP andresulting national ambitions on Access andBenefit Sharing (ABS) of genetic resourceshave generated several national regulatoryregimes fraught with unintended consequences(1). Anticipated benefits from thecommercial use of genetic resources, especiallythose that might flow to local or indigenouscommunities because of regulatedaccess to those resources, have largely beenexaggerated and not yet realized. Instead,national regulations …